Search

Your search keyword '"Perno CF"' showing total 874 results

Search Constraints

Start Over You searched for: Author "Perno CF" Remove constraint Author: "Perno CF"
874 results on '"Perno CF"'

Search Results

1. Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

2. CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases

3. Transmitted drug resistance to integrase based first-line HIV antiretroviral regimens in the Mediterranean Europe

6. Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches

7. Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients

8. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

9. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

10. Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

11. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

12. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART

13. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

15. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

16. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

17. Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

18. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

20. A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection

21. HEFFICON: HIV Effectiveness Italian Conference

22. A hyper-glycosilation of HBV surface major hydrophilic correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro

23. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

24. Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life

25. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

26. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

27. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

28. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

29. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

30. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

31. Two Different Patterns of Mutations are Involved in the Genotypic Resistance Score for Atazanavir Boosted Versus Unboosted by Ritonavir in Multiple Failing Patients

32. Eighteen months lamivudine prophylaxis of occult HBV infection (OBI) reactivation and standard therapy of overt chronic infection in oncohematologic immunosuppressed patients: an interim analysis

33. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014

34. Thymosin alpha 1 potentiates the release by CD8+ cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro

35. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients

36. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

37. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

38. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

39. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

40. No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

41. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage

43. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

44. Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997-2013

46. Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting

48. Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens

50. Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice

Catalog

Books, media, physical & digital resources